Podcast
#42: Preventing Rh Disease, the evolution from discovery to ongoing challenges
Duration: 25 Minutes
Nov 20, 2024
In our latest Science Bytes podcast episode, Dr. Steven Spitalnik, Professor of Pathology at Columbia University, takes us through the inspiring journey of Rh Disease prevention. From groundbreaking discoveries to today’s biggest challenges, Dr. Spitalnik brings clarity to this important, often-overlooked field.
This educational podcast activity is brought to you by QuidelOrtho Corporation., and is not certified for continuing medical education. QuidelOrtho Corporation sponsors the program, and the speaker must present information following applicable FDA requirements.
About our Speaker:
About our Speaker:
Dr Steven Spitalnik
Professor, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons of Columbia University
Medical Staff, New York Presbyterian/Columbia.
Dr. Spitalnik is a Professor in the Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons of Columbia University, and a member of the Medical Staff at New York Presbyterian/Columbia. He has authored over 250 publications and served as an investigator on more than 30 grants and contracts including Principal investigator on more than 20 of those grants. Additionally, he has sponsored more than 15 Training Grants. Dr. Spitalnik is a member of multiple professional societies, including the Association for the Advancement of Blood and Biotherapies (AABB) and the International Society for Blood Transfusion (ISBT). He has served on multiple committees within these organizations and was on the Board of Directors for the AABB. He has received multiple society awards and was elected to the Hall of Fame of the AABB Foundation (previously the National Blood Foundation). Dr. Spitalnik is the Founding Member and Executive Director of the Worldwide Initiative for Rh Disease Eradication, otherwise known as WIRhE.
Dr. Spitalnik is a Professor in the Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons of Columbia University, and a member of the Medical Staff at New York Presbyterian/Columbia. He has authored over 250 publications and served as an investigator on more than 30 grants and contracts including Principal investigator on more than 20 of those grants. Additionally, he has sponsored more than 15 Training Grants. Dr. Spitalnik is a member of multiple professional societies, including the Association for the Advancement of Blood and Biotherapies (AABB) and the International Society for Blood Transfusion (ISBT). He has served on multiple committees within these organizations and was on the Board of Directors for the AABB. He has received multiple society awards and was elected to the Hall of Fame of the AABB Foundation (previously the National Blood Foundation). Dr. Spitalnik is the Founding Member and Executive Director of the Worldwide Initiative for Rh Disease Eradication, otherwise known as WIRhE.
In this episode, you’ll learn:
- The development of treatments to prevent Rh disease and how they transformed maternal-fetal health
- Insights on preventing the production of anti-Rh antibodies
- The critical mission of the Worldwide Initiative for Rh Disease Eradication (WIRhE)
